Oxford Immunotec Reports First Quarter 2016 Financial Results

Go back to Oxford Immunotec Reports First Quarter 2016 Financial Results

Oxford (OXFD) Reports In-Line Q1 EPS

May 3, 2016 8:37 AM EDT

Oxford (NASDAQ: OXFD) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $17.1 million versus the consensus estimate of $16.96 million.

GUIDANCE:

Oxford sees Q2 2016 revenue of $17.4-18.2 million, versus the consensus of $17.9... More